ArticleNorthern clinics of Istanbul2025

Infection and infestation-related adverse events of ocrelizumab: A disproportionality analysis using FDA adverse event reporting system.

Nesrin Caglayan DumanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.